Yayın:
Oleuropein Mitigates Acrylamide-Induced Nephrotoxicity by Affecting Placental Growth Factor Immunoactivity in the Rat Kidney

dc.contributor.authorKıymet Kübra Tüfekci
dc.contributor.authorMusa Tatar
dc.date.accessioned2026-01-05T22:55:06Z
dc.date.issued2023-10-26
dc.description.abstractOleuropein is one of the main components of the antioxidant properties of olive leaves. Placental growth factor is an important regulator in angiogenesis and inflammation, its levels being variable in pathological conditions. In this study, we aimed to examine changes in placental growth factor expression and the effect of oleuropein, found in olive leaves, in rats exposed to acrylamide nephrotoxicity.Twenty-four male Wistar albino rats were allocated into 4 groups. The control group received saline solution only. The oleuropein group received oleuropein (4.2 mg/kg), the acrylamide group received acrylamide (5 mg/kg), and the acrylamide and oleuropein group received acrylamide (5 mg/kg) and oleuropein (4.2 mg/kg). All substances were administered via gastric gavage for 21 days. Kidney tissues were removed at the end of the study and subjected to histopathological, stereological, and immunohistochemical procedures.Histopathological examination revealed dilatation, vacuolization, and degeneration in the proximal and distal tubules and increased placental growth factor immunoreactivity in the acrylamide group. Cavalieri volume analysis revealed increased cortex, distal, and proximal tubule volumes (P < .01).Oleuropein significantly attenuated acrylamide-induced kidney injury by altering placental growth factor immunoreactivity. Placental growth factor immunoreactivity can be used as a marker of acrylamide nephrotoxicity, and oleuropein may counteract acrylamide-induced kidney injury.
dc.description.urihttps://doi.org/10.5152/eurasianjmed.2023.23043
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/37909193
dc.description.urihttp://dx.doi.org/10.5152/eurasianjmed.2023.23043
dc.description.urihttps://doaj.org/article/4398461241b240ce863250df423e4c76
dc.identifier.doi10.5152/eurasianjmed.2023.23043
dc.identifier.endpage233
dc.identifier.openairedoi_dedup___::330cfc5903b80153bbc019db87b45e24
dc.identifier.pubmed37909193
dc.identifier.scopus2-s2.0-85175239900
dc.identifier.startpage228
dc.identifier.urihttps://hdl.handle.net/20.500.12597/43447
dc.identifier.volume55
dc.identifier.wos001127636200011
dc.publisherAVES YAYINCILIK A.Ş.
dc.relation.ispartofThe Eurasian Journal of Medicine
dc.rightsOPEN
dc.subjectMedicine (General)
dc.subjectR5-920
dc.subjectOriginal Article
dc.subject.sdg3. Good health
dc.titleOleuropein Mitigates Acrylamide-Induced Nephrotoxicity by Affecting Placental Growth Factor Immunoactivity in the Rat Kidney
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Kıymet Kübra Tüfekci","name":null,"surname":null,"rank":1,"pid":null},{"fullName":"Musa Tatar","name":null,"surname":null,"rank":2,"pid":null}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"und","label":"Undetermined"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Medicine (General)"},"provenance":null},{"subject":{"scheme":"keyword","value":"R5-920"},"provenance":null},{"subject":{"scheme":"keyword","value":"Original Article"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Oleuropein Mitigates Acrylamide-Induced Nephrotoxicity by Affecting Placental Growth Factor Immunoactivity in the Rat Kidney","subTitle":null,"descriptions":["Oleuropein is one of the main components of the antioxidant properties of olive leaves. Placental growth factor is an important regulator in angiogenesis and inflammation, its levels being variable in pathological conditions. In this study, we aimed to examine changes in placental growth factor expression and the effect of oleuropein, found in olive leaves, in rats exposed to acrylamide nephrotoxicity.Twenty-four male Wistar albino rats were allocated into 4 groups. The control group received saline solution only. The oleuropein group received oleuropein (4.2 mg/kg), the acrylamide group received acrylamide (5 mg/kg), and the acrylamide and oleuropein group received acrylamide (5 mg/kg) and oleuropein (4.2 mg/kg). All substances were administered via gastric gavage for 21 days. Kidney tissues were removed at the end of the study and subjected to histopathological, stereological, and immunohistochemical procedures.Histopathological examination revealed dilatation, vacuolization, and degeneration in the proximal and distal tubules and increased placental growth factor immunoreactivity in the acrylamide group. Cavalieri volume analysis revealed increased cortex, distal, and proximal tubule volumes (P < .01).Oleuropein significantly attenuated acrylamide-induced kidney injury by altering placental growth factor immunoreactivity. Placental growth factor immunoreactivity can be used as a marker of acrylamide nephrotoxicity, and oleuropein may counteract acrylamide-induced kidney injury."],"publicationDate":"2023-10-26","publisher":"AVES YAYINCILIK A.Ş.","embargoEndDate":null,"sources":["Crossref","Eurasian J Med","Eurasian Journal of Medicine, Vol 55, Iss 3, Pp 228-233 (2023)"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"The Eurasian Journal of Medicine","issnPrinted":null,"issnOnline":null,"issnLinking":null,"ep":"233","iss":null,"sp":"228","vol":"55","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::330cfc5903b80153bbc019db87b45e24","originalIds":["10.5152/eurasianjmed.2023.23043","50|doiboost____|330cfc5903b80153bbc019db87b45e24","od_______267::feca191cda0f115a3594e6beb34ab149","37909193","PMC10724718","oai:pubmedcentral.nih.gov:10724718","50|od_______267::feca191cda0f115a3594e6beb34ab149","50|doajarticles::2384cba61cf4fe4426c5cbc4ddb5cfa9","oai:doaj.org/article:4398461241b240ce863250df423e4c76"],"pids":[{"scheme":"doi","value":"10.5152/eurasianjmed.2023.23043"},{"scheme":"pmid","value":"37909193"},{"scheme":"pmc","value":"PMC10724718"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":6,"influence":2.7695668e-9,"popularity":6.7954353e-9,"impulse":6,"citationClass":"C5","influenceClass":"C5","impulseClass":"C4","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.5152/eurasianjmed.2023.23043"}],"type":"Article","urls":["https://doi.org/10.5152/eurasianjmed.2023.23043"],"publicationDate":"2023-10-26","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"37909193"},{"scheme":"pmc","value":"PMC10724718"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.5152/eurasianjmed.2023.23043"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/37909193"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.5152/eurasianjmed.2023.23043"}],"license":"http://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (http://creativecommons.org/licenses/by/4.0/)","type":"Other literature type","urls":["http://dx.doi.org/10.5152/eurasianjmed.2023.23043"],"publicationDate":"2023-10-01","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.5152/eurasianjmed.2023.23043"}],"type":"Article","urls":["https://doaj.org/article/4398461241b240ce863250df423e4c76"],"publicationDate":"2023-10-01","refereed":"nonPeerReviewed"}],"isGreen":true,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar